DE602004023659D1 - Standardisiertes und optimiertes quantitatives reverse-transkriptase Echtzeit-Polymerasekettenreaktionsverfahren zum Nachweis von minimalen Resterkrankungen bei Leukämie - Google Patents

Standardisiertes und optimiertes quantitatives reverse-transkriptase Echtzeit-Polymerasekettenreaktionsverfahren zum Nachweis von minimalen Resterkrankungen bei Leukämie

Info

Publication number
DE602004023659D1
DE602004023659D1 DE602004023659T DE602004023659T DE602004023659D1 DE 602004023659 D1 DE602004023659 D1 DE 602004023659D1 DE 602004023659 T DE602004023659 T DE 602004023659T DE 602004023659 T DE602004023659 T DE 602004023659T DE 602004023659 D1 DE602004023659 D1 DE 602004023659D1
Authority
DE
Germany
Prior art keywords
detection
leukemia
standardized
residual disease
minimal residual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004023659T
Other languages
English (en)
Inventor
Jean Gabert
Emmanuel Beillard
Wanli Bi
Dongen Jacques Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix Marseille Universite
Universite de la Mediterranee
Original Assignee
Universite de la Mediterranee
Universite de la Mediterranee Aix Marseille II
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de la Mediterranee, Universite de la Mediterranee Aix Marseille II filed Critical Universite de la Mediterranee
Publication of DE602004023659D1 publication Critical patent/DE602004023659D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DE602004023659T 2003-03-07 2004-03-08 Standardisiertes und optimiertes quantitatives reverse-transkriptase Echtzeit-Polymerasekettenreaktionsverfahren zum Nachweis von minimalen Resterkrankungen bei Leukämie Expired - Lifetime DE602004023659D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290572A EP1454994A1 (de) 2003-03-07 2003-03-07 Standardisiertes und optimiertes quantitatives Reverse-Transkriptase-Echtzeit-Polymerasekettenreaktionsverfahren zum Nachweis von minimalen Resterkrankungen bei Leukämie

Publications (1)

Publication Number Publication Date
DE602004023659D1 true DE602004023659D1 (de) 2009-11-26

Family

ID=32799106

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004023659T Expired - Lifetime DE602004023659D1 (de) 2003-03-07 2004-03-08 Standardisiertes und optimiertes quantitatives reverse-transkriptase Echtzeit-Polymerasekettenreaktionsverfahren zum Nachweis von minimalen Resterkrankungen bei Leukämie

Country Status (7)

Country Link
US (2) US20060240434A1 (de)
EP (5) EP1454994A1 (de)
JP (1) JP4706863B2 (de)
AT (2) ATE445716T1 (de)
DE (1) DE602004023659D1 (de)
ES (2) ES2370339T3 (de)
WO (1) WO2004078020A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206920B2 (en) * 2007-03-26 2012-06-26 Arnold Ganser Diagnostic assay for the specific treatment of acute myeloid leukemia
CN101624621B (zh) * 2008-07-11 2012-01-18 北京大学人民医院 一种定量检测BCR/ABL mRNA水平的试剂盒
US9777332B2 (en) 2011-03-31 2017-10-03 St. Jude Children's Research Hospital Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
JP2015508644A (ja) * 2012-02-08 2015-03-23 インサイト ジェネティクス インコーポレイテッド 癌の診断および治療のためのｒｏｓ１の融合体に関する方法および組成物
MA35216B1 (fr) * 2012-09-13 2014-07-03 Mascir Sondes et amorces pour la detection du gene bcr-abl en reaction duplex
CN102925556B (zh) * 2012-09-29 2014-09-17 童永清 一种检测m BCR融合基因mRNA表达量的试剂盒
CN102876799B (zh) * 2012-10-18 2014-01-01 北京大学人民医院 用于检测mll相关融合基因的多重实时定量pcr试剂盒
MA36330B1 (fr) * 2013-10-10 2016-04-29 Mascir Morrocan Foundation For Advanced Science Innovation & Res Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du traitement et de la maladie residuelle
EP3201358A1 (de) * 2014-10-02 2017-08-09 Université de Montréal Marker für schlechte prognose von akuter myeloischer leukämie und verwendungen davon
JP6531312B2 (ja) * 2014-10-17 2019-06-19 東洋鋼鈑株式会社 Ｂｃｒ−ａｂｌ阻害剤耐性関連変異の検出方法及びこれを用いたｂｃｒ−ａｂｌ阻害剤耐性を予測するためのデータ取得方法
WO2016183679A1 (en) * 2015-05-21 2016-11-24 Université de Montréal Prognostic markers of acute myeloid leukemia survival
CN106399462A (zh) * 2015-07-27 2017-02-15 上海睿玻生物科技有限公司 一种bcr-abl融合基因扩增试剂盒和检测试剂盒
RU2638800C2 (ru) * 2015-12-29 2017-12-15 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Способ определения маркеров наличия опухолевых в-лимфобластов
CN107674914A (zh) * 2016-08-02 2018-02-09 熊术道 一步单管法定量rt‑pcr检测慢性髓系白血病bcr‑abl1基因的表达量
CN108823306A (zh) * 2017-05-03 2018-11-16 杭州赫玛生物科技有限公司 检测白血病细胞的系统和方法
CN108676848B (zh) * 2018-05-31 2022-04-22 上海科医联创医学检验所有限公司 用于检测融合基因的混合基因、标准质粒、试剂盒及其制备方法
CN109554472A (zh) * 2018-12-18 2019-04-02 武汉迪安医学检验实验室有限公司 一种用于检测tel-aml1融合基因的试剂盒
CN111235148A (zh) * 2020-03-26 2020-06-05 迈杰转化医学研究(苏州)有限公司 一种dna探针池、包含其的淋巴瘤检测试剂盒及其制备方法和应用
CN111733238B (zh) * 2020-05-26 2021-08-03 广州血康陆道培生物技术有限公司 一种鉴别PML-RARα融合基因3种剪切体的引物组及其试剂盒和应用
CN112280866A (zh) * 2020-11-24 2021-01-29 福州艾迪康医学检验所有限公司 荧光定量pcr技术筛查急性早幼粒细胞白血病相关14种融合基因的方法、引物及探针
CN113637756A (zh) * 2021-08-18 2021-11-12 武汉良培医学检验实验室有限公司 一种用于多靶点单孔同时检测的探针组及其试剂盒
CN116970704B (zh) * 2023-08-22 2024-05-17 迈杰转化医学研究(苏州)有限公司 一种检测bcr-abl激酶区突变的引物探针组合及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004080A1 (fr) * 1995-07-14 1997-02-06 Fuji Yakuhin Kogyo Kabushiki Kaisha Nouvelle proteine et anticorps monoclonal specifique a cette derniere
AU2001239953A1 (en) * 2000-03-01 2001-09-12 University Of South Florida Methods of modulating cell-adhesion mediated drug resistance
ES2281416T3 (es) * 2000-04-03 2007-10-01 Corixa Corporation Metodos, composiciones y sistemas para la deteccion y monitorizacion del cancer de mama.
WO2002002739A2 (en) * 2000-06-29 2002-01-10 University Of Florida Ubiquitin ligase
US7363168B2 (en) * 2001-10-02 2008-04-22 Stratagene California Adaptive baseline algorithm for quantitative PCR
US7198897B2 (en) * 2001-12-19 2007-04-03 Brandeis University Late-PCR
DE10209071A1 (de) * 2002-02-28 2003-09-25 Roboscreen Ges Fuer Molekulare Standardisierte Polynukleotidsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung
US20030170724A1 (en) * 2002-03-08 2003-09-11 Anderson David C. Methods of identifying target polypeptides

Also Published As

Publication number Publication date
ES2337301T3 (es) 2010-04-22
EP1806415A2 (de) 2007-07-11
EP1806416A2 (de) 2007-07-11
JP4706863B2 (ja) 2011-06-22
WO2004078020A3 (en) 2005-03-31
EP2204457A3 (de) 2011-01-19
EP1601796A2 (de) 2005-12-07
ATE518004T1 (de) 2011-08-15
EP1806415A3 (de) 2007-07-18
US20110223595A1 (en) 2011-09-15
ES2370339T3 (es) 2011-12-14
JP2006519601A (ja) 2006-08-31
EP1601796B1 (de) 2011-07-27
EP1454994A1 (de) 2004-09-08
EP1806416B9 (de) 2010-03-10
WO2004078020A2 (en) 2004-09-16
EP1806416B1 (de) 2009-10-14
US20060240434A1 (en) 2006-10-26
EP2204457A2 (de) 2010-07-07
ATE445716T1 (de) 2009-10-15
EP1806416A3 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
DE602004023659D1 (de) Standardisiertes und optimiertes quantitatives reverse-transkriptase Echtzeit-Polymerasekettenreaktionsverfahren zum Nachweis von minimalen Resterkrankungen bei Leukämie
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
DE60334471D1 (de) Primer für nukleinsäureamplifikation in pcr-basierten klonalitätsstudien
ATE557083T1 (de) Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität
ATE459710T1 (de) Dna-polymerasefusionen und deren verwendungen
WO2005089508A3 (en) Dna sequence detection by limited primer extension
SE0202867D0 (sv) New sequencing method
ATE437945T1 (de) Verfahren zur amplifikation und sequenzierung von nukleinsäuren
WO2003087297A8 (en) Infectious disease microarray
EP1712618A4 (de) Verfahren zur amplifikation von nukleinsäure und verfahren zum nachweis mutierter nukleinsäure unter verwendung desselben
ATE411401T1 (de) Verfahren zur stabilisierung von testreagentien, reagenzbehälter mit stabilisierten testreagentien und verwendung davon
DE602007011301D1 (de) Verfahren zum nachweis mutanter allele mit kombination von echtzeit-pcr und rems-pcr
ATE484515T1 (de) Dna-polymerase-mischungen und mutante dna- polymerasen
JP2006521799A5 (de)
EP1772523A3 (de) Polymerase-Kettenreaktionsverfahren unter Einsatz einer DNA-Polymerase mit Proofreading-Eigenschaften
DE69121821D1 (de) Nukleotid-Sequenzen nützlich als typenspezifische Sonden, PCR Primers und LCR Sonden zur Amplifikation und zum Nachweis von humanem Papillomavirus, sowie dazu verwendete Kits und Verfahren
ATE533847T1 (de) Verfahren für den nachweis und die quantifizierung einer endogenen dna-sequenz aus weizen
EP2058406A3 (de) RNA-Detektionsverfahren
ATE497022T1 (de) Verfahren zur amplifikation von nukleinsäure
ATE526418T1 (de) Verbesserte zusammensetzungen zur in-vitro- amplifikation von nukleinsäuren
DE602005023586D1 (de) Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
WO2003072721A3 (en) Detection by sliding template amplification
WO2002020845A3 (en) Ultra yield amplification reaction
DE602004030036D1 (de) Multiplexanalyse von Nukleinsäuren zur Bestimmung von Genotypen des humanen Papillomavirus
ATE455864T1 (de) Verfahren zum nachweis von in einer polymerase- kettenreaktion amplifizierten nukleinsäuremolekülen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition